News

scientists now know that it is linked to a roughly 30 per cent greater risk of stroke and a 10 per cent greater risk of heart attack, especially within a year after having it. Lee and her ...
Observational studies at the SCAI meeting favored the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) over ...